台股 » 個股 » 國光生 » 籌碼相關 » 券商分點績效

國光生

(4142)
可現股當沖
  • 股價
    27.90
  • 漲跌
    ▼0.30
  • 漲幅
    -1.06%
  • 成交量
    701
  • 產業
    上市 生技醫療類股▼0.62%
  • 633人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
國光生 (4142)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/03/27     後一日»

券商獲利排行 - 2024/03/27

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  3.39%99.91.198.9901102026.826.826.927.9
  3.93%23.2023.22222026.826.8027.9
  3.39%190.118.91721426.826.826.827.9
  4.10%16.5016.51515026.826.8027.9
  3.78%15.2015.21515026.926.9027.9
  4.05%130.212.81112126.726.726.927.9
  3.80%12.2012.21212026.926.9027.9
  4.49%120121010026.726.7027.9
  4.10%110111010026.826.8027.9
  4.10%110111010026.826.8027.9
  3.53%9.509.5101002727027.9
  3.53%9.509.5101002727027.9
  4.10%8.808.888026.826.8027.9
  3.91%8.408.488026.926.9027.9
  4.05%7.607.677026.826.8027.9
  4.49%7.207.266026.726.7027.9
  4.20%6.706.766026.826.8027.9
  2.91%6.2-0.16.368226.826.826.827.9
  4.49%60655026.726.7027.9
  4.30%5.705.755026.826.8027.9
  4.10%5.505.555026.826.8027.9
  3.91%5.205.255026.926.9027.9
  1.51%5.2-1.97.2713626.826.926.627.9
  4.49%4.804.844026.726.7027.9
  3.58%4.80.24.645126.826.82727.9
  0.97%4.12.91.30161526.726.626.827.9
  4.89%3.903.933026.626.6027.9
  4.10%3.303.333026.826.8027.9
  4.04%3.203.233026.826.8027.9
  3.91%3.103.133026.926.9027.9
  3.72%30333026.926.9027.9
  4.79%2.502.522026.626.6027.9
  4.49%2.402.422026.726.7027.9
  4.30%2.302.322026.826.8027.9
  4.30%2.302.322026.826.8027.9
  4.30%2.302.322026.826.8027.9
  4.30%2.302.322026.826.8027.9
  4.20%2.202.222026.826.8027.9
  4.20%2.202.222026.826.8027.9
  4.20%2.202.222026.826.8027.9
  4.10%2.202.222026.826.8027.9
  4.10%2.202.222026.826.8027.9
  4.10%2.202.222026.826.8027.9
  2.61%2.102.123126.926.926.927.9
  3.91%2.102.122026.926.9027.9
  3.91%2.102.122026.926.9027.9
  1.08%1.4-0.6225326.826.926.727.9
  5.08%1.301.311026.626.6027.9
  2.43%1.30.11.212126.726.726.827.9
  4.89%1.301.311026.626.6027.9

券商虧損排行 - 2024/03/27

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -4.89%-390-39-3003026.6026.627.9
  -3.72%-36.90.2-37.1-3333726.826.726.827.9
  -3.28%-25.5-0.7-24.8-2272926.826.926.827.9
  -3.88%-15.60-15.6-1501526.9026.927.9
  -2.20%-12.90.2-13.1-11112226.726.726.727.9
  -4.59%-12.20-12.2-1001026.7026.727.9
  -4.49%-120-12-1001026.7026.727.9
  -4.14%-11.10-11.1-1001026.8026.827.9
  -3.72%-100-10-1001026.9026.927.9
  -4.10%-9.90-9.9-90926.8026.827.9
  -3.62%-9.70-9.7-901026.926.926.927.9
  -3.91%-9.40-9.4-90926.9026.927.9
  -3.48%-9.30.1-9.4-911026.826.826.927.9
  -3.44%-9.20-9.2-821026.826.826.827.9
  -4.58%-8.50-8.5-70726.7026.727.9
  -2.90%-8.5-0.4-8.1-741126.826.826.727.9
  -3.77%-8.10-8.1-80826.9026.927.9
  -3.86%-7.20-7.2-70726.9026.927.9
  -4.89%-6.50-6.5-50526.6026.627.9
  -4.04%-6.50-6.5-60626.8026.827.9
  -3.85%-6.20-6.2-60626.9026.927.9
  -3.78%-6.10-6.1-60626.9026.927.9
  -4.49%-60-6-50526.7026.727.9
  -3.66%-5.90-5.9-60626.9026.927.9
  -4.30%-5.70-5.7-50526.8026.827.9
  -4.30%-5.70-5.7-50526.8026.827.9
  -4.10%-5.50-5.5-50526.8026.827.9
  -3.91%-5.20-5.2-50526.9026.927.9
  -3.91%-5.20-5.2-40526.926.826.927.9
  -3.91%-5.20-5.2-50526.9026.927.9
  -3.87%-5.20-5.2-50526.9026.927.9
  -3.79%-5.10-5.1-50526.9026.927.9
  -3.53%-4.70-4.7-5052702727.9
  -4.30%-4.60-4.6-30426.826.926.827.9
  -3.96%-4.20-4.2-40426.8026.827.9
  -3.96%-4.20-4.2-40426.8026.827.9
  -3.91%-4.20-4.2-40426.9026.927.9
  -3.91%-4.20-4.2-40426.9026.927.9
  -3.81%-4.10-4.1-40426.9026.927.9
  -4.49%-3.60-3.6-30326.7026.727.9
  -4.10%-3.30-3.3-30326.8026.827.9
  -4.10%-3.30-3.3-30326.8026.827.9
  -3.98%-3.20-3.2-30326.8026.827.9
  -4.89%-2.60-2.6-20226.6026.627.9
  -2.28%-2.4-0.2-2.2-22426.826.926.827.9
  -4.30%-2.30-2.3-20226.8026.827.9
  -4.10%-2.20-2.2-20226.8026.827.9
  -4.10%-2.20-2.2-20226.8026.827.9
  -1.34%-2.20-2.2-14626.826.826.827.9
  -2.68%-2.10.1-2.2-21326.826.726.827.9
國光生去年營運轉虧 今年拚重回成長軌道Anue鉅亨-2024/03/13
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
國光生 相關文章